Top compounds associated with response to LNX1


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.18 0.0005
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.11 0.001
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.1 0.001
mRNA ML203 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA paclitaxel gCSI pan-cancer AAC -0.17 0.002
mRNA AUY922 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA SN-38 GDSC1000 pan-cancer AAC -0.1 0.002
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.002
Download CSV